Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acoustic Resonance Therapy for Treatment of Empty Nose Syndrome: A Prospective, Phase 2 Randomized Clinical Trial

NCT07215013 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT07215013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07215013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acoustic Resonance Therapy for Treatment of Empty Nose Syndrome: A Prospective, Phase 2 Randomized Clinical Trial
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 31, 2028
Completion date
July 31, 2030
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

empty nose syndrome, nasal obstruction